Eli Lilly and Company

Enterprise Data Management - Operations Engineer

Indianapolis, Indiana, United States

Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Information Technology, Data ManagementIndustries

Requirements

Candidates should possess a Bachelor’s degree in Information Technology or a related field, along with a minimum of 3 years of work experience in Information Technology DevOps and 3 years of hands-on experience with AWS Services such as S3, RDS, Lambda, Glue, EC2, Redshift, CloudWatch, CloudTrail, and IAM, complemented by 3 years of experience utilizing GitHub and CI/CD for deployments.

Responsibilities

The Enterprise Data Management - Operations Engineer will report to an Executive Director in Indianapolis, working closely with data engineers, business analysts, quality, data owners, and stakeholders to efficiently manage, monitor, and optimize the flow of quality data for data sharing and analytics, including resolving incidents and problems, managing technology lifecycle changes, and conducting configuration changes.

Skills

AWS S3
AWS RDS
AWS Lambda
AWS Glue
AWS EC2
AWS Redshift
AWS CloudWatch
AWS CloudTrail
AWS IAM
GitHub
CI/CD
DevOps
Configuration Management

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI